216 related articles for article (PubMed ID: 30174490)
21. Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma.
Chen JH; Faquin WC; Lloyd RV; Nosé V
Mod Pathol; 2011 May; 24(5):739-49. PubMed ID: 21358618
[TBL] [Abstract][Full Text] [Related]
22. The ultrasonography features of hyalinizing trabecular tumor of the thyroid are more consistent with its benign behavior than cytology or frozen section readings.
Lee S; Han BK; Ko EY; Oh YL; Choe JH; Shin JH
Thyroid; 2011 Mar; 21(3):253-9. PubMed ID: 21190434
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with the sensitivity of fine-needle aspiration cytology for the diagnosis of follicular variant papillary thyroid carcinoma.
Chai YJ; Suh H; Yi JW; Yu HW; Lee JH; Kim SJ; Won JK; Lee KE
Head Neck; 2016 Apr; 38 Suppl 1():E1467-71. PubMed ID: 26580475
[TBL] [Abstract][Full Text] [Related]
24. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS
Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
[TBL] [Abstract][Full Text] [Related]
25. Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
Kaliszewski K; Diakowska D; Wojtczak B; Rudnicki J
PLoS One; 2020; 15(7):e0236257. PubMed ID: 32692768
[TBL] [Abstract][Full Text] [Related]
26. Multifocality related factors in papillary thyroid carcinoma.
Gur EO; Karaisli S; Haciyanli S; Kamer E; Genc H; Atahan K; Haciyanli M
Asian J Surg; 2019 Jan; 42(1):297-302. PubMed ID: 30585170
[TBL] [Abstract][Full Text] [Related]
27. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonographic features and clinical characteristics of Warthin-like variant of papillary thyroid carcinoma.
Kim GR; Shin JH; Hahn SY; Ko EY; Oh YL
Endocr J; 2016 Apr; 63(4):329-35. PubMed ID: 26806192
[TBL] [Abstract][Full Text] [Related]
29. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
30. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
[TBL] [Abstract][Full Text] [Related]
31. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?
Xu B; Farhat N; Barletta JA; Hung YP; Biase D; Casadei GP; Onenerk AM; Tuttle RM; Roman BR; Katabi N; Nosé V; Sadow P; Tallini G; Faquin WC; Ghossein R
Endocrine; 2018 Jan; 59(1):143-150. PubMed ID: 29204912
[TBL] [Abstract][Full Text] [Related]
32. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
33. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
34. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
35. Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma.
Sezer A; Celik M; Yilmaz Bulbul B; Can N; Tastekin E; Ayturk S; Ustun F; Guldiken S; Sut N
Bosn J Basic Med Sci; 2017 May; 17(2):144-151. PubMed ID: 28284178
[TBL] [Abstract][Full Text] [Related]
36. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
37. Nodule Size Effect on Diagnostic Performance of Ultrasonography and Computed Tomography for Papillary Thyroid Carcinoma.
Li JW; Chang C; Chen JY; Shi ZT; Chen M
Curr Med Imaging Rev; 2019; 15(5):489-495. PubMed ID: 32008556
[TBL] [Abstract][Full Text] [Related]
38. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Ultrasonography Features and K-TIRADS for Isthmic and Lobar Papillary Thyroid Carcinomas: A Single-Center Study.
Lee YJ; Kim DW; Shin GW; Park JY; Choo HJ; Park HK; Ha TK; Kim DH; Jung SJ; Park JS; Moon SH; Ahn KJ; Baek HJ
Front Endocrinol (Lausanne); 2020; 11():328. PubMed ID: 32582025
[No Abstract] [Full Text] [Related]
40. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]